Literature DB >> 19235591

YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels.

Stavroula Baritaki1, Anthoula M Chatzinikola, Antonios F Vakis, Nikolaos Soulitzis, Dimitris A Karabetsos, Ioannis Neonakis, Benjamin Bonavida, Demetrios A Spandidos.   

Abstract

In this study we examined by QRT-PCR the mRNA expression of TGF-beta 1, IGF-1, EGF, FGF-2 and YY1 in human brain tumors. Our findings introduce YY1, for the first time, as a novel gene implicated in brain gliomatogenesis and meningioma establishment. We present a positive correlation between the autocrine expression of YY1 and TGF-beta 1, IGF-1 and FGF-2, known to be involved in the progression of gliomas and meningiomas. We suggest that mRNA profiling of the above genes in the early stages of disease development could be useful for prognostic purposes, and these genes can be considered as potential targets for therapeutic approaches against brain tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235591     DOI: 10.1080/07357900802210760

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  18 in total

Review 1.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

Review 2.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

3.  Expression of YY1 in Differentiated Thyroid Cancer.

Authors:  Jéssica Arribas; Josep Castellví; Ricard Marcos; Carles Zafón; Antonia Velázquez
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

4.  A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets.

Authors:  Xinghao Fu; Feihong Ji; Qi He; Xinguang Qiu
Journal:  J Immunol Res       Date:  2022-06-24       Impact factor: 4.493

5.  Upregulation of Ying Yang 1 (YY1) suppresses esophageal squamous cell carcinoma development through heme oxygenase-1.

Authors:  Judong Luo; Xifa Zhou; Xin Ge; Pengfei Liu; Jianping Cao; Xujing Lu; Yang Ling; Shuyu Zhang
Journal:  Cancer Sci       Date:  2013-09-05       Impact factor: 6.716

6.  Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.

Authors:  Matthew E Hardee; Ariel E Marciscano; Christina M Medina-Ramirez; David Zagzag; Ashwatha Narayana; Scott M Lonning; Mary Helen Barcellos-Hoff
Journal:  Cancer Res       Date:  2012-06-12       Impact factor: 13.312

7.  CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.

Authors:  Charalabos Pothoulakis; Monica Torre-Rojas; Marco A Duran-Padilla; Jonathan Gevorkian; Odysseas Zoras; Emmanuel Chrysos; George Chalkiadakis; Stavroula Baritaki
Journal:  Int J Cancer       Date:  2017-10-12       Impact factor: 7.316

8.  The transcription factor YY1 is a substrate for Polo-like kinase 1 at the G2/M transition of the cell cycle.

Authors:  Raed Rizkallah; Karen E Alexander; Ari Kassardjian; Bernhard Lüscher; Myra M Hurt
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

Review 9.  Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis.

Authors:  Karrie Mei-Yee Kiang; Xiao-Qin Zhang; Gilberto Ka-Kit Leung
Journal:  Cancers (Basel)       Date:  2015-07-29       Impact factor: 6.639

Review 10.  Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression.

Authors:  Vaishali Kashyap; Benjamin Bonavida
Journal:  Genes Cancer       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.